HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vitamin C Pricing In Supreme Court, Vitamin D QHC Petition Fails: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Supreme Court will hear an appeal of a circuit court's reversal of a ruling that two vitamin C importers violated US antitrust laws by conspiring to fix prices; Bayer request for vitamin D QHC for multiple sclerosis rejected; Inno-Vita warned on cleansing drug claims; and 'Prevention' clear in ABC-AHP-NCNPR program name.

You may also be interested in...

Supreme Court Vitamin C Price-Fixing Decision Could Juice Litigation Against Foreign Businesses Broadly

US businesses in any industry could use the Supreme Court's ruling that federal courts have leeway in whether to recognize a foreign country's laws as applicable in a firm's defense against unfair business practices and similar civil complaints, say attorneys tracking class-action litigation vitamin C marketers Animal Science Products and Ranis Co. filed against multiple Chinese firms supplying the ingredient.

Roche's Tecentriq Disappoints In Ovarian Cancer Study

PD-1/PDL-1 inhibitors have not proved effective for ovarian cancer on their own or in combinations. Now Roche's Tecentriq, combined with the firm's blockbuster Avastin, has suffered a similar fate to Merck KGaA and Pfizer's Bavencio in failing to improve survival.

Greater Uptake Must Become Belgium’s ‘New Normal’

Increased uptake for generics and biosimilars must become Belgium’s “new normal” in the wake of the coronavirus crisis, local off-patent industry association Medaxes has argued.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts